978 results on '"Heine, Robert J."'
Search Results
2. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
3. Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
4. Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.
5. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies ( SURPASS programme)
6. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes
7. Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM)
8. 722-P: Tirzepatide Improves Multiple Aspects of Beta-Cell Function
9. Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?
10. Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis
11. Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation
12. Efficacy and Safety of Tirzepatide versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
13. Survival as a function of HbA 1c in people with type 2 diabetes: a retrospective cohort study
14. Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism
15. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study
16. Insulin Pumps Are Still Debatable For Type 1 Diabetes
17. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
18. Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort
19. Determinants of postprandial triglyceride and glucose responses after two consecutive fat-rich or carbohydrate-rich meals in normoglycemic women and in women with type 2 diabetes mellitus: the Hoorn Prandial Study
20. Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus
21. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes
22. Survival as a function of HbA.sub.1c in people with type 2 diabetes: a retrospective cohort study
23. Comment on Zhang et al. Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better? Diabetes Care 2014;37: 1338–1345
24. Unlocking the opportunity of tight glycaemic control: Promise ahead: the role of inhaled insulin in clinical practice
25. Refractive properties of the healthy human eye during acute hyperglycemia
26. The effect of acute hyperglycemia on retinal thickness and ocular refraction in healthy subjects
27. Nonalcoholic fatty liver disease and cardiovascular disease risk
28. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study
29. Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
30. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening study
31. Prandial glucose regulation in the glucose triad: Emerging evidence and insights
32. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial
33. Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence
34. Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62: 2595–2604
35. The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
36. The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway
37. Sagittal abdominal diameter: no advantage compared with other anthropometric measures as a correlate of components of the metabolic syndrome in elderly from the Hoorn Study 1–3
38. Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Shared Care Versus Secondary Outpatient Care in The Netherlands
39. Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients
40. Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
41. Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients?
42. Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial
43. The Impact of Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on Glycemia
44. Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism
45. Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
46. Associations Between Features of Glucose Exposure and A1C: The A1C-Derived Average Glucose (ADAG) Study
47. Combined Risk Allele Score of Eight Type 2 Diabetes Genes Is Associated With Reduced First-Phase Glucose-Stimulated Insulin Secretion During Hyperglycemic Clamps
48. Gene Variants in the Novel Type 2 Diabetes Loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B Affect Different Aspects of Pancreatic β-Cell Function
49. Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels
50. Vitamin D and mortality in older men and women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.